Ivan Oransky

Articles by Ivan Oransky

The Scientist Placeholder Image

Progeria effort pays off

The Scientist Placeholder Image

How not to launch a journal

The Scientist Placeholder Image

When journal editors get fired

The Scientist Placeholder Image

Stem cells for heart disease? First things first

The Scientist Placeholder Image

From bench to emergency room bedside

The Scientist Placeholder Image

Epigenetics and the heart

The Scientist Placeholder Image

The State of the Science Union

The Scientist Placeholder Image

Fraud: Do as I say, not as I do

The Scientist Placeholder Image

Turkeys: The world's smartest birds

The Scientist Placeholder Image

All Hwang human cloning work fraudulent

The Scientist Placeholder Image

Nature got lucky, and so did I

The Scientist Placeholder Image

Diversity in the life sciences

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies